To overview |
|
| | |||
| Ad hoc statement |
| Carl Zeiss Meditec expected to report revenue of approximately EUR 432m for the first half of the current financial year | Downloads and Links | ||
 | RTF Documents
english (7861 KB)Further Information 
Deutsche Version | ||
| JENA/Germany, 02.04.2012. Carl Zeiss Meditec AG [ISIN: DE0005313704) will report revenue of approximately EUR 432m for the first half of the current financial year (1 October 2011 - 31 March 2012). This corresponds to an increase of about 15 percent over the equivalent period last year. Earnings before interest and tax are also expected to increase compared with the previous year. All the regions and strategic business units contributed to the gratifying upturn in business. A key factor behind this significant increase in sales was again the gratifying performance of the Microsurgery strategic business unit and the dynamic growth in the Asia/Pacific region. The final business figures will be announced in the 6 month report, scheduled for publication on 15 May 2012. Petra Rettenmaier Director Corporate Communications Carl Zeiss Meditec AG Phone: +49 3641 220-331 Fax: +49 3641 220-117 E-Mail: 
press@meditec.zeiss.com
Number: 0034-2012-ENG OP |
|